Lead
"Her lips turned red after egg." "He broke out in hives after something with peanuts in it." The first time a parent sees a food allergy reaction, two questions follow immediately: Is this going to happen again? Do we have to stop giving this food entirely?
Fear is a natural response — but when fear drives prolonged food avoidance, it can create a different kind of risk. Research on food allergy has made substantial advances over the past decade, and the science now complicates the instinct to simply avoid. Knowing what has happened and what to do about it is what converts fear into a practical judgment.
Food Allergy in Infants and Young Children
Food allergy prevalence in young children is estimated at 5–10% [5]. In Japan, the most common culprit is hen's egg, followed by cow's milk and wheat. Peanut allergy is less prevalent in Japan than in the United States or United Kingdom but has been increasing in recent years [2,5].
Prognosis varies by allergen: more than 90% of egg allergies resolve naturally by school age, whereas only 20–25% of peanut allergies resolve [3]. Allergic reactions generally appear within 15 minutes to two hours of ingestion.
Severity in Three Tiers
The clinical spectrum of food allergy reactions is wide. A rough three-tier framework helps with triage:
Mild (can often be managed by observation):
- Itching or redness around the lips or mouth
- Partial facial hives
- Mild redness or swelling of the eyes
Moderate (medical evaluation is appropriate):
- Widespread hives spreading to the trunk and extremities
- Repeated vomiting or abdominal pain
- Swelling of the entire face
Severe — anaphylaxis: a severe, rapidly progressing allergic reaction affecting multiple body systems (skin, breathing, blood pressure) — a medical emergency requiring immediate epinephrine (emergency response required):
- Throat tightening, hoarseness, or wheeze (airway symptoms)
- Difficulty breathing, cyanosis
- Loss of consciousness or marked lethargy
- Hypotension (low blood pressure)
Anaphylaxis is an acute systemic reaction involving multiple organ systems simultaneously and requires prompt epinephrine administration and emergency care [4]. If an epinephrine auto-injector (EpiPen): a pre-filled, easy-to-use injection device delivering a single dose of adrenaline to quickly counter severe allergic reactions has been prescribed, it should be used without hesitation.
A Changed Paradigm — Early Introduction and Allergy Prevention
The old guidance was to delay introducing high-risk foods in infants with eczema or a family history of allergy, on the assumption that avoidance protects. This has been substantially revised.
The LEAP trial (Du Toit et al. 2015) enrolled high-risk infants — those with eczema or existing egg allergy — and randomized them to early peanut consumption starting at 4–11 months or to avoidance. At age five, the early-consumption group had a peanut allergy rate of 1.9%, against 13.7% in the avoidance group — an 81–86% reduction in allergy development [1].
The PETIT trial (Natsume et al. 2017), conducted in Japanese infants with eczema, found that introducing small amounts of heated egg protein from six months of age reduced egg allergy rates at 12 months by 63% compared with controls [2].
The evidence suggests that "avoiding it because it's scary" may itself raise the risk of allergy developing. This does not mean testing all foods without preparation — risk levels vary with eczema severity, family history, and existing allergic history, and consultation with a pediatrician before introducing higher-risk foods is recommended for higher-risk infants [5].
Oral Food Challenges
When food allergy is suspected, continued self-directed avoidance or home "test bites" are not the recommended path. Definitive diagnosis relies on an oral food challenge — a structured procedure at a qualified facility in which the food is given in incremental amounts under observation. The procedure can confirm that elimination is unnecessary (releasing the family from an unneeded restriction) or establish a safe intake level.
Skin prick tests and serum IgE measurements are supplementary tools, not diagnostic tests in isolation. A positive IgE result does not automatically mean the food must be avoided or that a clinical allergy is present. Diagnosis always requires a clinical conversation with a physician.
Translating Evidence into Everyday Decisions
- Introduce new foods in small amounts, in the morning: Choose a time when a medical appointment is reachable if a reaction occurs
- If there is eczema or a family history of allergy: Discuss egg and peanut introduction plans with a pediatrician — delaying is not the only option, and may not be the right one
- Know the signs of anaphylaxis: Airway, blood pressure, and consciousness symptoms warrant emergency care or epinephrine use
- Record the reaction: What was eaten, when, what symptoms appeared — kept in a parenting log, this information is directly useful at a medical visit and at oral food challenges
Summary
Fear of food allergy can drive prolonged avoidance, but avoidance itself may raise allergy risk. With appropriate knowledge of severity tiers and of what current evidence says about early introduction, it is possible to avoid both unnecessary restriction and complacency about genuine emergencies. Knowledge changes fear into judgment.
Related Articles
- 237 Infant Eczema, Seborrheic Dermatitis, and Atopic Dermatitis: Telling Them Apart — Infant skin conditions and their link to allergy risk
- 239 Atopic Dermatitis: Proactive Therapy — Standard management for atopic dermatitis
- 242 The Dual Allergen Exposure Hypothesis — The theoretical and trial-based explanation for why delaying introduction may backfire
References
- Du Toit G, Roberts G, Sayre PH, et al.; LEAP Study Team. Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med. 2015;372(9):803–813. doi:10.1056/NEJMoa1414850. PMID: 25705822.
- Natsume O, Kabashima S, Nakazato J, et al.; PETIT Study Team. Two-step egg introduction for prevention of egg allergy in high-risk infants with eczema (PETIT): a randomised, double-blind, placebo-controlled trial. Lancet. 2017;389(10066):276–286. doi:10.1016/S0140-6736(16)31418-0. PMID: 27916234.
- Sampson HA. Food allergy: past, present and future. Allergol Int. 2016;65(4):363–369. doi:10.1016/j.alit.2016.08.006. PMID: 27645769.
- Turner PJ, Gowland MH, Sharma V, et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992–2012. J Allergy Clin Immunol. 2015;135(4):956–963.e1. doi:10.1016/j.jaci.2014.10.021. PMID: 25468189.
- Japanese Society of Pediatric Allergy and Clinical Immunology. Food Allergy Clinical Practice Guideline 2021. Tokyo: Kyowa Kikaku; 2021.
- Perkin MR, Logan K, Tseng A, et al.; EAT Study Team. Randomized trial of introduction of allergenic foods in breast-fed infants. N Engl J Med. 2016;374(18):1733–1743. doi:10.1056/NEJMoa1514210. PMID: 26943128.